The epidemiology of dermatofibrosarcoma protuberans incidence, metastasis, and death among various population groups: A Surveillance, Epidemiology, and End Results database analysis
Topical nanoencapsulated cannabidiol cream as an innovative strategy combating UV-A–induced nuclear and mitochondrial DNA injury: A pilot randomized clinical study
Evaluation of anticancer therapy-related dermatologic adverse events: Insights from Food and Drug Administration's Adverse Event Reporting System dataset
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
Interleukin 23 versus interleukin 12/23 inhibitors on preventing incidental psoriatic arthritis in patients with psoriasis? A real-world comparison from the TriNetX Global Collaborative Network
Enhanced disease-specific survival in lentigo maligna melanoma patients treated with Mohs surgery over wide local excision: A retrospective cohort analysis of the Surveillance, Epidemiology, and End Results database
Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 3 trial
Investigating racial and ethnic disparities in vulvar squamous cell carcinoma: A retrospective cohort analysis of the Surveillance, Epidemiology, and End Results database
Adverse events in cemiplimab therapy for locally advanced or metastatic cutaneous squamous cell carcinoma: A global propensity-matched retrospective cohort study
Impact of store-and-forward consumer to physician teledermatology as compared to in-person visits for patients with periorificial dermatitis: A retrospective study
Analysis of dermatology away rotations available on the Visiting Student Learning Opportunities database and implications for diversity in dermatology: A national cross-sectional study
JAAD Game Changers: To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis
Response to the article by Hill and Lipner entitled “Numbers of nail procedures performed by physician assistants and nurse practitioners among Medicare beneficiaries increased 2013-2021�
Response to Hasan et al’s “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study�
Response to Shih et al. “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study�
Reconsidering the relationship between academic dermatology and the pharmaceutical industry: Balancing ethics and education of free biologic samples in dermatology
Response to Hasan et al’s “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study�
Effective response to upadacitinib in patients affected by prurigo nodularis and by atopic dermatitis with a predominant prurigo nodularis pattern: A multicenter case series study